Patents by Inventor Matthias Schieker

Matthias Schieker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DOSING REGIMEN FOR AN NLRP3 INHIBITOR IN THE TREATMENT OF OSTEOARTHRITIS
    Publication number: 20250082611
    Abstract: The present disclosure relates to the field of pharmacy, particularly to an NLRP3 inhibitor for use in the treatment of osteoarthritis. The disclosure also relates to an NLRP3 inhibitor or a pharmaceutical combination comprising an NLRP3 inhibitor, and at least one further therapeutic agent, for use in the treatment of osteoarthritis; to a method for the treatment of osteoarthritis that involves administering an NLRP3 inhibitor or the combination; and to the use of an NLRP3 inhibitor or the combination for the manufacture of a medicament for the treatment of osteoarthritis.
    Type: Application
    Filed: July 20, 2022
    Publication date: March 13, 2025
    Inventors: Laura COLEMAN, Christopher FARADY, Ewa GATLIK, Matthias SCHIEKER
  • METHOD OF TREATING TENDINOPATHY USING INTERLEUKIN-17 (IL-17)
    Publication number: 20230331834
    Abstract: The present disclosure relates to methods for treating tendinopathy, e.g., rotator cuff tendinopathy, using IL-17 antagonists, e.g., secukinumab. Also disclosed herein are uses of IL-17 antagonists. e.g., IL-17 antibodies, such as secukinumab, for treating tendinopathy patients, as well as medicaments, dosing regimens, pharmaceutical formulations, dosage forms, and kits for use in the disclosed uses and methods.
    Type: Application
    Filed: January 9, 2023
    Publication date: October 19, 2023
    Inventors: Gerard Bruin, Shea Carter, Frank Kolbinger, Iain McInnes, Neal Millar, Linda Mindeholm, Matthias Schieker, Eckhard Weber
  • METHOD OF TREATING TENDINOPATHY USING INTERLEUKIN-17 (IL-17)
    Publication number: 20210179702
    Abstract: The present disclosure relates to methods for treating tendinopathy, e.g., rotator cuff tendinopathy, using IL-17 antagonists, e.g., secukinumab. Also disclosed herein are uses of IL-17 antagonists, e.g., IL-17 antibodies, such as secukinumab, for treating tendinopathy patients, as well as medicaments, dosing regimens, pharmaceutical formulations, dosage forms, and kits for use in the disclosed uses and methods.
    Type: Application
    Filed: November 1, 2018
    Publication date: June 17, 2021
    Inventors: Gerard Bruin, Shea Carter, Frank Kolbinger, Iain McInnes, Neal Millar, Linda Mindeholm, Matthias Schieker, Eckhard Weber
  • Chain-extending poloxamers, thermoreversible hydrogels formed by them which include biological materials, and medicinal applications of same
    Patent number: 10406231
    Abstract: According to the invention, thermoreversible hydrogels are provided, which are prepared from chain-extended poloxamers, having advantageous properties. In addition, the invention provides thermoreversible hydrogels, including biological materials, and a process for the preparation thereof, thermoreversible hydrogels including living cells, application systems for pharmaceutical applications, and an in-vitro-method for forming a composition on a surface.
    Type: Grant
    Filed: December 17, 2013
    Date of Patent: September 10, 2019
    Inventor: Matthias Schieker
  • CHAIN-EXTENDING POLOXAMERS, THERMOREVERSIBLE HYDROGELS FORMED BY THEM WHICH INCLUDE BIOLOGICAL MATERIALS, AND MEDICINAL APPLICATIONS OF SAME
    Publication number: 20150335749
    Abstract: According to the invention, thermoreversible hydrogels are provided, which are prepared from chain-extended poloxamers, having advantageous properties. In addition, the invention provides thermoreversible hydrogels, including biological materials, and a process for the preparation thereof, thermoreversible hydrogels including living cells, application systems for pharmaceutical applications, and an in-vitro-method for forming a composition on a surface.
    Type: Application
    Filed: December 17, 2013
    Publication date: November 26, 2015
    Inventors: Matthias Schieker, Hinrich Wiese, Uta Moll